"10.1371_journal.pone.0139944","plos one","2015-10-20T00:00:00Z","Mieke C E Hermans; Janneke G J Hoeijmakers; Catharina G Faber; Ingemar S J Merkies","Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands; Department of Neurology, Spaarne Hospital, Hoofddorp, The Netherlands","Analyzed the data: MCEH ISJM CGF. Wrote the paper: MCEH JGJH ISJM CGF.","Dr. Merkies competing interests: Scientific Advisory Boards: Participation in steering committees of the Talecris ICE Study, CSL Behring, LFB, Novartis and Octapharma (a research foundation at the University of Maastricht received the honoraria on behalf of Dr. Merkies); Funding for travel or speaker honoraria: Talecris company, travel funding for presentations on the ICE trial at EFNS meetings (2009, 2010); Research Support, Commercial Entities: Talecris Talents program for PeriNomS Study; Research Support, Government Entities: European Union 7th Framework Programme, grant n°602273, 2013; Research Support, Foundations and Societies: GBS/CIDP foundation international, grant for PeriNomS study. Dr. Faber: European Union 7th Framework Programme (grant n°602273); Prinses Beatrix Spierfonds (W.OR12-01); Grifols Lamepro. Dr. Hermans and Dr. Hoeijmakers have declared that no competing interests exist.","2015","10","Mieke C E Hermans","MCEH",4,FALSE,NA,NA,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
